The abstract is read at the publisher; the summary is JClub's.
Myeloid-enriched heparanase (HPSE) in human and NOD mouse islets is linked to intraislet heparan sulfate (HS) barrier degradation and stronger IFN-γ–STAT1–associated inflammation.
- Why it matters: The intraislet HS barrier is important for β-cell survival, but how HPSE and HS fragments shape T1D immune inflammation is not fully defined.
- What they did: The study integrated single-cell RNA sequencing from human and mouse islets and peripheral immune cells with genetic mouse models and muparfostat pharmacological inhibition, then tested effects on macrophage polarization and immune infiltration.
- The result: Myeloid-specific Hpse deficiency improved glucose tolerance and reduced iNOS+ macrophages and T cells, while islet-specific Hpse overexpression accelerated autoimmune diabetes; muparfostat preserved the HS barrier and improved glucose homeostasis in nonobese T1D models.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.